Human Germline Manipuation and Cloning as Women's Issues
By Marcy Darnovsky,
GeneWatch
| 06. 30. 2001
While the prospect of genetically "redesigned" people challenges humanity as a whole, it particularly threatens groups that historically have been disempowered. And because human germline engineering and cloning are so closely tied to reproduction, they are of special concern to women.
The New Eugenics and the Commercialization of Reproduction
Already, prenatal screening and preimplantation diagnosis make it possible to eliminate fetuses and embryos with a number of identifiable genetic conditions. As disability rights activists point out, these developments put women in the position of "eugenic gatekeepers." Inheritable genetic modification, to whatever extent it turns out to be technically possible, would amplify the powers of eugenic selection many times over.
If a new "free-market eugenics" were to take hold, who would actually exercise "consumer preference" for genetic "enhancements?" Who would decide what was on offer?
Human cloning and germline engineering would move decisions about reproduction further away from women, not only toward doctors and technicians but also toward marketers proffering the "enhancements" developed by biotech companies. Women could find themselves simultaneously losing ever more control of their own childbearing experiences, and...
Related Articles
By Ian Sample, The Guardian | 07.04.2024
Biological models of human embryos that can develop heartbeats, spinal cords and other distinctive features will be governed by a code of practice in Britain to ensure that researchers work on them responsibly.
Made from stem cells, they mimic, to...
By Kevin Davies, Genetic Engineering & Biotechnology News | 06.27.2024
Physician-scientist Matthew Porteus, MD, PhD, has been a mainstay in the genome editing field for more than two decades. He trained at Stanford University Medical School before completing his residency and hematology/oncology fellowship at Boston Children’s Hospital/Dana Farber Cancer Institute...
By Peter Aldhous, Scientific American | 07.02.2024
In June a notice posted on the website of the journal Nature set a new scientific record. It withdrew what is now the most highly cited research paper ever to be retracted.
The study, published in 2002 by Catherine Verfaillie...
By Robert F. Service, Science | 07.04.2024
Image by Ed Uthman from Flickr
Last year, the U.S. Food and Drug Administration (FDA) approved two gene therapy procedures that can treat and, in some cases essentially cure sickle cell disease, a genetic blood disorder that causes pain and...